This week's top stories in cardiology:
Many cardiac cath, electrophysiology lab directors receive big industry payments
These payments were substantially higher than those made to local interventional cardiologists and electrophysiologist.
Two trials support shorter DAPT
DAPT with a twist: Continuing the P2Y12 inhibitor instead of aspirin.
Do black patients with type 2 diabetes gain cardiac benefit from the SGLT2 and GLP-1 drugs?
New findings suggest there is no effect on cardiovascular outcomes, although the analysis has limitations
Top stories from the American Heart Association scientific sessions
Vascepa gains event-reduction nod; diabetes ups ischemic risks
Post-STEMI events less likely in women; bariatric surgery may lower stroke risk
New trick for old drug; Vascepa cost effective for CV reduction
Card Talk: TAVR and glass ceilings
ISCHEMIA trial, DAPA-HF, and valsartan recall: AHA Special
Long-awaited ISCHEMIA results to change practice, DAPA-HF elevates dapagliflozin for HFrEF
Pot heightens stroke, arrhythmia risks; keeping low LDL and BP slashes lifetime heart risk
How risk factors in childhood translate to CV outcomes in adulthood
Driving while defibrillating; hypertension holds greater risk in black patients
AFib hits Native Americans hard; TAVR shown durable, safe after 5 years
Practice changing prevention data from ESC 2019 Part II
Statins tied to skin, soft tissue infections; new Card Talk episode
Troponin protocol rapidly rules out MI; hidden risk of moderate aortic stenosis
Sun sets on longer DAPT after PCI; inactivity boosts post-MI risk
Cardiology dead last as women’s IM subspecialty choice
An antiplatelet surprise; Europeans go low in cholesterol guidelines
SGLT-2 inhibitors and more practice changing data from ESC 2019
Overweight BMI surpasses 'normal' and introducing the 'Card Talk' segment
Dapagliflozin transforms into heart failure drug
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Peter Attia Drive
The Doctor’s Farmacy with Mark Hyman, M.D.